Fierce Pharma

SEPTEMBER 8, 2024

The Keytruda-beating data from Akeso and Summit’s ivonescimab that oncology industry watchers had been awaiting are here. | The Keytruda-beating data from Akeso and Summit’s ivonescimab that oncology industry watchers had been awaiting are here. The China-only data are impressive, signaling the PD-1/VEGF bispecific antibody’s potential as a new standard of care in non-small cell lung cancer.

324

324

MedCity News

SEPTEMBER 8, 2024

As the FDA continues its work to ensure that AI is deployed safely within healthcare, there are a couple prevalent issues that frequently pop up, said Luke Ralston, one of the agency’s reviewers. The post These Are 2 of The Biggest Issues with Healthcare AI, According to an FDA Reviewer appeared first on MedCity News.

Healthcare 109

Healthcare Healthcare FDA 109

pharmaphorum

SEPTEMBER 8, 2024

CDC reports the first-ever US case of an H5 strain of avian influenza without a known occupational exposure to sick or infected animals

108

108

Pharmaceutical Commerce

SEPTEMBER 9, 2024

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Meghan Mullooly, Archbow Consulting’s Vice President, offers advice to pharma manufacturers for successfully applying digital solutions to their patient support programs.

Pharma 66

Pharma Manufacturing Patients 66

Advertisement

Fierce Pharma

SEPTEMBER 9, 2024

When AstraZeneca’s Alexion picked up rare disease specialist Syntimmune in 2018 for $ | A Delaware judge agreed that AstraZeneca's Alexion breached its contract and failed to pay a milestone payment of $130 million tied to the development of a now scrapped autoimmune candidate originally developed by Syntimmune.

162

162

MedCity News

SEPTEMBER 8, 2024

NeOnc Technologies is preparing to go public via the less common path of a direct listing as it continues mid-stage testing of its intranasally administered brain cancer drug. Meanwhile, the mostly stagnant biotech IPO pipeline is showing new signs of life with two large stock market debuts expected this week. The post A Biotech Going Through the Nose to Treat the Brain Plots Alternative Path to Public Markets appeared first on MedCity News.

Marketing 102

Marketing Biopharma Pharma 102

Clarivate

SEPTEMBER 9, 2024

Did you know that over 80% of executives rank innovation among their top three priorities, yet only 10% are satisfied with their organization’s innovation performance [1] ? This striking gap underscores the critical need for robust patent benchmarking data to inform better decision-making and drive innovation success. Our latest report, “Innovators to Watch 2024,” shines a spotlight on the organizations on the cusp of breaking into the Clarivate Top 100 Global Innovators rankings.

Networking 59

Networking Electronics Leads 59

Fierce Pharma

SEPTEMBER 9, 2024

Three months on, Eli Lilly has closed the books on its search for a new chief financial officer. And as with its previous CFO, Anat Ashkenazi, the company didn’t have to look far. | Lilly on Monday revealed that it’s slotting 23-year company veteran Lucas Montarce into the finance chief role after the pharma’s previous CFO, Anat Ashkenazi, announced her departure in early June.

Management 191

Management 191

MedCity News

SEPTEMBER 8, 2024

The ruling, which limits federal agencies’ power to interpret ambiguous laws, now leaves crucial legislation like the Mental Health Parity and Addiction Equity Act vulnerable to court challenges, potentially unraveling years of hard-won progress. The post Supreme Court’s Chevron Decision Threatens Decades of Progress in Access to Mental Health Care appeared first on MedCity News.

105

105

pharmaphorum

SEPTEMBER 8, 2024

Results of Ideate-Lung01 trial at WCLC back up MSD and Daiichi Sankyo's decision to move anti-B7-H3 ADC I-Dxd into phase 3 for small cell lung cancer

65

65

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTimes

SEPTEMBER 9, 2024

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs

Doctors 82

Doctors 82

Fierce Pharma

SEPTEMBER 9, 2024

After opting out of Teva’s $4.25 billion national opioid settlement last year, the city of Baltimore has secured its own payout through a settlement deal worth $80 million. | The city scored its own deal after opting not to join in on Teva's $4.25 billion national opioid settlement.

130

130

MedCity News

SEPTEMBER 9, 2024

Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services. The post There is Still a Significant Need for Community Pharmacies appeared first on MedCity News.

Retail 77

Retail Medical Prescription Management 77

PharmExec

SEPTEMBER 9, 2024

Results of the FENopta study found that after one year of treatment, 96% of patients experienced no relapses of multiple sclerosis, with an annualized relapse rate of just 0.04.

Patients 52

Patients 52

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Clarivate

SEPTEMBER 8, 2024

A new Clarivate report [1] explores Standard Essential Patents Landscape of 5G RedCap The RedCap (Reduced Capability) feature was introduced by 3GPP in Release-17 to cater to the growing demand for 5G New Radio (NR) devices with reduced complexity. 5G RedCap, also known as NR-Light, addresses the need for simpler, energy efficient and cost effective 5G NR devices.

Distribution 52

Distribution Leads 52

Fierce Pharma

SEPTEMBER 9, 2024

With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing facility in its home country. The U.K. | With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing facility in its home country.

Manufacturing 130

Manufacturing Medicine 130

MedCity News

SEPTEMBER 9, 2024

In an age where consumers have more options than ever about where to receive their care, improving the financial experience through embedded finance can give providers an advantage in an increasingly competitive marketplace. The post How Embedded Finance Creates a Better Patient Experience appeared first on MedCity News.

Patients 67

Patients Competition Physicians 67

Spotio

SEPTEMBER 9, 2024

Short for revenue operations, RevOps is the alignment of Marketing, Sales, and Support functions to improve the customer experience and increase revenue growth. RevOps is important because it helps connect internal teams, drive consistent revenue growth, increase customer happiness and retention, and boost company-wide efficiency metrics. In other words, RevOps will help your organization do what it does more effectively.

Sales 52

Sales Sales process Prospecting Leads 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaTech

SEPTEMBER 9, 2024

In this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.

52

52

Fierce Pharma

SEPTEMBER 10, 2024

After much anticipation and concern, the BIOSECURE Act—which would prevent U.S. companies from working with certain Chinese biotech service providers—has passed a key threshold. | Late Monday, the U.S. House of Representatives voted 306-81 in favor of the BIOSECURE Act, which was introduced in January and seeks to halt federal contracts with five named Chinese life-sci companies: WuXi AppTec, WuXi Biologics, BGI Group, MGI and Complete Genomics.

130

130

MedCity News

SEPTEMBER 8, 2024

As poverty, food insecurity, inadequate housing, and complex comorbidities persist, it is essential that rural healthcare leaders have tools and systems in place to address the health of their neighbors. The post Rural Healthcare Goes Beyond Care: Targeting SDOH to Improve Health Outcomes appeared first on MedCity News.

Healthcare 71

Healthcare Healthcare Food Transportation 71

European Pharmaceutical Review

SEPTEMBER 9, 2024

A report from Frontier Economics has highlighted the major benefit industry clinical trials have had on UK’s economy. For instance, it has supported its growth and the job market, the research showed. Of the 65,000 jobs generated, 21,000 individuals were employed directly by the pharmaceutical industry to deliver trials, according to the data. While industry clinical trials in the UK have reduced , the Association of the British Pharmaceutical Industry (ABPI) stated that if the activity assumes

Pharmaceutical 52

Pharmaceutical Medicine Government Pharma 52

Advertisement

Distribution

PharmaTech

SEPTEMBER 9, 2024

CDER’s Jonathan Chapman, senior policy advisor, and Takeda’s Paulien Groll, head of Compliance Excellence, discussed how companies can be proactive with their CAPA strategies instead of reactive, at the 2024 PDA/FDA Joint Regulatory Conference.

FDA 52

FDA 52

Infuse Medical

SEPTEMBER 9, 2024

With uses going beyond entertainment and into vital sectors like surgery, augmented reality (AR) is transforming the healthcare sector. AR gives surgeons better vision by overlaying digital data onto the physical world, therefore enabling them to execute difficult treatments with more confidence and accuracy. By 2024 there will be an estimated 1.7 billion mobile augmented reality (AR) users worldwide, a rise of 1.5 billion from the 200 million seen in 2015.

Doctors 52

Doctors Healthcare Healthcare Medicine 52

MedCity News

SEPTEMBER 9, 2024

The American Medical Association released a new report on Monday on pharmacy benefit managers. It explained that there is low competition among PBMs and high vertical integration with payers. The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News.

Competition 61

Competition Marketing Medical Management 61

PharmExec

SEPTEMBER 9, 2024

In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, and the potential health risks associated with them.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTech

SEPTEMBER 8, 2024

Drug stability impacts efficacy and safety. Choosing the right packaging is crucial. This paper outlines key factors affecting stability and provides packaging guidelines.

Safety 52

Safety 52

Infuse Medical

SEPTEMBER 9, 2024

As the healthcare industry is moving forward to the latest technologies, interactive patient demonstrations are a must development needed so far. Of course, patient medical device education and counseling are to educate them about diseases, procedures, and the treatments followed. It is not only to educate but also to enhance compliance with medical treatment regimens.

Education 52

Education Medical Patients Healthcare Provider 52

MedCity News

SEPTEMBER 9, 2024

The weight loss results for the Terns Pharmaceuticals drug TERN-601 come from a four-week Phase 1 clinical trial. Terns is one of several companies developing oral GLP-1 obesity medications that could become alternatives to currently available injectable products from this drug class. The post Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study appeared first on MedCity News.

Leads 61

Leads Pharma Pharmaceutical Medical 61

pharmaphorum

SEPTEMBER 9, 2024

AI biomarker could help identify lung cancer patients most likely to benefit from AstraZeneca and Daiichi Sankyo's TROP2 drug Dato-DXd.

Patients 60

Patients 60

Advertiser: ZoomInfo

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

Marketing